English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
PRNewsWire - Health
Mit 7,5 Millionen GBP dotierter Longitude-ALS-Forschungspreis ausgeschrieben
Mit 7,5 Millionen GBP dotierter Longitude-ALS-Forschungspreis ausgeschrieben
Share this via
Full Coverage
Se lanza el Premio Longitude sobre ELA de £7,5 millones
Se lanza el Premio Longitude sobre ELA de £7,5 millones
Share this via
Full Coverage
£7.5 million Longitude Prize on ALS launches
£7.5 million Longitude Prize on ALS launches
Share this via
Full Coverage
Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial
Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection P...
Share this via
Full Coverage
First
Prev.
104
105
106
107
108
109
110
Next
Last
Trending
1.
Joann's closing
2.
Texas Tech basketball
3.
UNC basketball
4.
Monster Hunter Wilds
5.
Ketamine
6.
Macron
7.
UPMC Memorial shooting
8.
Eagles
9.
Hims stock
10.
Joel Embiid
Popular News
The mortgage market hopes for rate cuts amid war moves
1 week ago
15
The mortgage market hopes for rate cuts amid war moves
Share this via
BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
1 week ago
13
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulat...
Share this via
Ukraine returns bodies of 3 Russian soldiers repatriated as ...
1 week ago
12
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry...
Share this via
BrightGene presenteert positieve fase 2 gegevens voor de dua...
1 week ago
11
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbehe...
Share this via
BrightGene présente des données positives de phase 2 pour so...
1 week ago
10
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la ge...
Share this via